QMS MEDICAL ALLIED S LTD

Operates in the healthcare services space, with a subsidiary, Saarathi Healthcare Private Limited, that runs patient support operations, CRM platforms, data management, call centre operations and digital workflows for healthcare clients. In July 2026, the subsidiary received a SOC 2 Type II certification valid for five years (July 14, 2026 to July 15, 2029), covering security, availability, processing integrity, confidentiality and privacy controls across these operations with no non-conformities noted. The parent reported FY26 revenue of ₹172.88 crore against total assets of ₹212.85 crore. The cost structure is light on materials, with employee costs at 8.8% of revenue and other operating expenses at 22.6% of revenue, while capex was 3.3% of revenue, pointing to a services-led model rather than a manufacturing one. In June 2026, the company migrated from the NSE SME/Emerge platform to the NSE Mainboard. The filings provided do not break out revenue by segment or describe the parent's activities outside the Saarathi Healthcare subsidiary.